Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials.

Mohamed T AbuelazmAhmed A IbrahimYehya KhlidjAmr BadrAhmed Mazen AminMohamad A ElzeftawyIbrahim GowailyAhmed Saad ElsaeidyBasel Abdelazeem

Published in: Journal of the Endocrine Society (2023)

Insulin icodec was associated with decreased HbA1C, increased TIR, with similar hypoglycemic and serious AEs. However, it was also associated with increased body weight and the incidence of any AEs.

Keyphrases

type diabetes
glycemic control
body weight
cardiovascular disease
systematic review
risk factors